A new Canadian-made medication could help people with diabetes who have gone into hypoglycemic shock.
Baqsimi is a nasal spray contains three milligrams of glucagon. It differs from previously-available glucagon treatments for hypoglycemic shock, or extremely low blood sugar, because it does not need to be mixed.
Lilly Canada, the company that initially made insulin widely available to the public in the 1920s, purchased Baqsimi from Quebec-based Locemia Solutions in 2015.
The medication was just approved by Health Canada and is now available both by prescription or over the counter.
Surrey-based endocrinologist Dr. Akshay Jain said having a pre-mixed glucagon that doesn’t need to be injected is game-changed for people with diabetes.
More here –> MapleRidgeNews.com